Atli FH, Manduz S., Katrancioglu N., et al. eNOS G894T polymorphism and abdominal aortic aneurysms. Angiology. 2009. IN PRESS.
2.
Ridker PM, Danielson E., Fonseca FA, et al, for the JUPITER Study GroupRosuvastatini to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207.
3.
Berkan O., Katrancioglu N., Ozker E., Ozerdem G., Bakici Z., Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009;57(2): 91-95.
4.
Nissen SE, Tuzcu EM, Schoenhagen P., et al, for the REVERSAL Investigators.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis a randomized controlled trial. JAMA. 2004;291(9):1071-1080.
